, Tracking Stock Market Picks
Enter Symbol:
Ariad Pharmaceuticals, Inc. (ARIA) [hlAlert]

down 22.34 %

Ariad Pharmaceuticals, Inc. (ARIA) rated Underweight with price target $6 by Barclays

Posted on: Tuesday,  Jan 19, 2016  1:25 PM ET by Barclays

Barclays rated Underweight Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) on 01/19/2016. Previously Barclays rated Underweight Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) on 10/10/2013.,
when the stock price was $5.42. Since then, Ariad Pharmaceuticals, Inc. has gained 28.78% as of 01/19/2016's recent price of $6.98.
If you would have followed the previous Barclays's recommendation on ARIA, you would have lost 22.34% of your investment in 831 days.

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/19/2016 1:25 PM Sell
5.40 6.00
as of 8/27/2015
1 Week up  8.03 %
1 Month up  21.48 %
3 Months up  21.66 %
1 YTD down  -2.34 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/10/2013 2:25 PM Sell
5.42 4.00
2/26/2013 1:25 PM Buy
20.80 29.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy